Wolters Kluwer Advances AI Strategy Through Microsoft Partnership and Share Buybacks

Wolters Kluwer accelerates €500M share buyback program and integrates its UpToDate clinical database into Microsoft Copilot, following strong 2025 results with 7% revenue growth.

The Dutch information services group Wolters Kluwer is making significant strategic moves on two fronts. In early March 2026, the company announced a major integration for its clinical knowledge database and simultaneously accelerated its capital return program through substantial share repurchases.

Share Repurchase Program in Full Swing

Alongside its strategic partnership news, Wolters Kluwer is actively executing its share buyback initiative. Between February 27 and March 4, the company purchased 80,106 of its own shares for €5.5 million, at an average price of €68.11 per share. Since the beginning of the year, total buybacks have reached €109.3 million, accounting for 1.46 million shares.

A broader program announced in February authorizes repurchases of up to €500 million throughout 2026. The shares acquired are slated to be cancelled to reduce share capital. The company has engaged a third-party intermediary to execute purchases worth €60 million, with this mandate running until May 4, 2026.

Strategic Integration with Microsoft's AI Ecosystem

A key development is the integration of Wolters Kluwer's UpToDate clinical reference database directly into Microsoft's Copilot ecosystem. This move connects the long-established medical knowledge resource with Microsoft Dragon Copilot, Microsoft 365 Copilot, and Microsoft Teams.

This integration will allow physicians and clinical teams to access evidence-based answers, complete with full source citations, within their everyday documentation and communication software. A distinguishing feature is that all Microsoft-generated content relying on UpToDate data will include complete citations to the underlying medical sources. This provides a layer of verifiable provenance often absent from generic generative AI models, which typically produce synthesized summaries without clear origin trails.

The UpToDate platform itself is a substantial asset. Maintained by over 7,600 medical specialists globally, it covers more than 13,000 clinical topics and is utilized at over 50,000 institutional sites.

Solid 2025 Performance Underpins Initiatives

These strategic and financial actions are built upon a robust full-year 2025 performance. Revenue reached €6.13 billion, marking a 7% increase on a constant-currency basis and 6% organic growth. Recurring revenues, which constitute 83% of total revenue, grew organically by 7%, with cloud software revenue surging 15%.

Adjusted operating profit climbed 9% on a constant-currency basis to €1.69 billion, pushing the margin up by 40 basis points to 27.5%. Adjusted free cash flow also saw strong growth, advancing 10% to €1.35 billion.

Notably, nearly 70% of the company's digital revenue now originates from AI-powered solutions. To further this momentum, Wolters Kluwer plans to increase its product development expenditure to 12-13% of revenue in 2026.

Consistent Dividend Growth Continues

The company's commitment to shareholder returns extends to its dividend. A final dividend of €1.59 per share will be proposed at the 2026 Annual General Meeting. This would bring the total dividend for 2025 to €2.52 per share, an 8% year-on-year increase. Wolters Kluwer has now maintained an unbroken and never-reduced dividend payout for two decades.

Investor attention now turns to the upcoming first-quarter 2026 results, scheduled for release on May 6. A key focus will be whether the Microsoft AI partnership begins to generate tangible operational momentum or if its initial impact is primarily reflected in elevated development costs.